Format

Send to

Choose Destination
J Oncol Pract. 2011 Mar;7(2):117-21. doi: 10.1200/JOP.2011.000212.

American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer.

Author information

1
University of Michigan, Ann Arbor, MI; Lurie Comp Cancer Center of Northwestern University, Chicago, IL; American Society of Clinical Oncology, Alexandria, VA.

Abstract

Journal of Clinical Oncology recently published ASCO's update to its guideline on the use of bone-modifying agents for patients with bone metastases, the scope of which was narrowed to the use of bone-modifying agents for patients with evidence of bone metastases.

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center